Female shock patients face delays in treatment and are less likely to receive approved interventions, says Suzanne Baron.

The syndrome of cardiogenic shock has been defined as the inability of the heart -- as a result of impairment of its pumping function -- to deliver sufficient blood flow to the tissues to meet ...

SGMC Health has successfully performed its first procedure using the Abiomed Impella 5.5 with SmartAssist, a minimally ...

This global, placebo-controlled, double-blinded trial aims to assess the efficacy of istaroxime, alongside standard treatments for SCAI Stage C cardiogenic shock. The study will evaluate several ...

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime ...

Interventional cardiologists share insights into the progress of procedures and devices such as Impella and TAVI for acute ...

We're all aware of the psychological pain of a broken heart – countless books, songs, and movies have been written and made ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...